Properties of mitochondrial DNA metabolising enzymes; implications for chemotherapy.
Eriksson
S
S
Department of Veterinary Medical Chemistry, Swedish University of Agricultural Sciences, Uppsala.
Xu
B
B
Clayton
D A
DA
D000998:Antiviral Agents / Q000494:pharmacology*; D004272:DNA, Mitochondrial / Q000378:metabolism*; D004259:DNA-Directed DNA Polymerase / Q000302:isolation & purification / Q000378:metabolism*; D003854:Deoxyribonucleotides / Q000378:metabolism*; D006678:HIV / Q000201:enzymology*; D007700:Kinetics; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism*; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D018894:Reverse Transcriptase Inhibitors; D012441:Saccharomyces cerevisiae / Q000201:enzymology; D013379:Substrate Specificity
D000998:Antiviral Agents; D004272:DNA, Mitochondrial; D003854:Deoxyribonucleotides; D011994:Recombinant Proteins; D018894:Reverse Transcriptase Inhibitors; D012194:RNA-Directed DNA Polymerase; D004259:DNA-Directed DNA Polymerase